Investment Summary

Adams Street Partners Invests In Cirius Therapeutics

On April 11, 2017, asset manager Adams Street Partners invested in life science company Cirius Therapeutics

Investment Highlights
  • This is Adams Street Partners’ 14th transaction in the Life Science sector.
  • This is Adams Street Partners’ 95th transaction in the United States.
  • This is Adams Street Partners’ 1st transaction in Michigan.

Investment Summary
Date 2017-04-11
Target Cirius Therapeutics
Sector Life Science
Investor(s) Adams Street Partners
Deal Type Venture

Target

Cirius Therapeutics

Kalamazoo, Michigan, United States
Cirius Therapeutics is a clinical-stage pharmaceutical company focused on the development of innovative therapies for the treatment of liver and metabolic diseases. Cirius is developing MSDC-0602K, a novel, once-daily, oral small molecule for the treatment of nonalcoholic fatty liver disease (NAFLD), which includes nonalcoholic steatohepatitis (NASH), with Type 2 diabetes. Cirius Therapeutics was founded in 2015 and is based in Kalamazoo, Michigan.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Adams Street Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

Category Asset Manager
Founded 1972
PE ASSETS 60.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.

DEAL STATS #
Overall 106 of 148
Sector (Life Science) 14 of 23
Type (Venture) 75 of 100
State (Michigan) 1 of 2
Country (United States) 95 of 136
Year (2017) 3 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-02-23 Fusion Pharmaceuticals

Hamilton, Ontario, Canada

Fusion Pharmaceuticals is a pharmaceutical company focused on the targeted alpha therapy field. Fusion will exploit its unique expertise in linking medical isotopes to targeting molecules to create highly effective therapeutics. Fusion Pharmaceuticals was formed in 2014 and is based in Hamilton, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-25 TeleSign

Marina del Rey, California, United States

TeleSign Corp. is a provider of Out-of-Band (OOB) authentication solutions for internet, software and financial transactions, identifying and substantially reducing online fraud and spam using a user's phone. TeleSign Corp. was established in 2005 and is headquartered in Marina del Rey, California.

Sell $230M
Mergr

Product

Company

Legal